The 30-day window

The 30-day window: post-acute spend is now yours.

MSKvalue Insights · July 2026 · For surgery-center and MSK service-line leaders

TEAM is not a quality program with a bonus attached. It is a repricing: for roughly 740 hospitals, mandatorily, since January 2026, the surgical episode’s target price includes everything Medicare pays for 30 days past discharge — the SNF stay, the home-health visits, the readmission. Spend that used to be someone else’s claim is now a deduction from your reconciliation. You didn’t acquire a post-acute network, but you acquired its bill.

Where the money actually moves

The OR is where episode conversations happen; the post-acute tail is where episode dollars move. The joint-replacement bundles that preceded TEAM taught a consistent lesson: the biggest, fastest savings came not from the hospital stay but from discharge disposition — fewer default SNF placements, shorter post-acute stays, home-based recovery for the patients who could do it safely. The components are easy to rank:

Under TEAM the discharge order is a purchase order. The person signing it is committing your facility’s money in a setting your facility has never instrumented.

The least-instrumented, highest-leverage part of the score

Your OR is measured to the minute and the unit cost. The home — where the scored month actually elapses — typically reports back to you as nothing at all until a claim arrives. That asymmetry is the opportunity, because home is the one episode component where modest, cheap interventions move the largest dollars:

The sequencing point

Post-acute discipline compounds with everything else on this site: the better-fitting primary discharges home sooner and revises less; the screened, educated patient uses fewer SNF days; the monitored recovery catches the day-9 problem before it becomes the day-12 readmission. None of it requires capital — it requires treating the 30 days after discharge as part of the operation, because as of this year, financially, it is.

Start the conversation →

Figures marked * are illustrative and program-dependent; not clinical, legal, or financial advice. MSKvalue assembles independent best-of-class products with the American Joint Replacement Registry as the outcomes backbone.